Gladstone Institutional Advisory LLC Humacyte, Inc. Transaction History

Gladstone Institutional Advisory LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$2.02 - $3.62 $152,156 - $272,676	-75,325 Reduced 86.16%	12,098 $25,000
Q3 2022 Jan 27, 2023	SELL	$1.22 - $5.14 $61,118 - $257,498	-50,097 Reduced 36.43%	87,423 $285,000
Q3 2022 Oct 20, 2022	SELL	$1.22 - $5.14 $61,118 - $257,498	-50,097 Reduced 36.43%	87,423 $285,000
Q2 2022 Jan 27, 2023	SELL	$3.21 - $7.86 $23,583 - $57,747	-7,347 Reduced 5.07%	137,520 $441,000
Q2 2022 Aug 15, 2022	SELL	$3.21 - $7.86 $23,583 - $57,747	-7,347 Reduced 5.07%	137,520 $441,000
Q1 2022 Jan 27, 2023	SELL	$4.65 - $7.4 $473,602 - $753,690	-101,850 Reduced 41.28%	144,867 $1.02 Million
Q1 2022 May 04, 2022	SELL	$4.65 - $7.4 $473,602 - $753,690	-101,850 Reduced 41.28%	144,867 $1.02 Million
Q4 2021 Jan 27, 2023	BUY	$7.25 - $11.6 $1.15 Million - $1.85 Million	159,294 Added 182.21%	246,717 $1.79 Million
Q4 2021 Feb 11, 2022	BUY	$7.25 - $11.6 $1.79 Million - $2.86 Million	246,717 New	246,717 $1.79 Million

149

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $472M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.